Exenatide-Pioglitazone Combo Tops Insulin in Type 2 Diabetes Exenatide-Pioglitazone Combo Tops Insulin in Type 2 Diabetes
The combination lowers HbA1c more effectively with less weight gain and hypoglycemia in type 2 diabetes patients poorly controlled on metformin plus a sulfonylurea in the Qatar study.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
More News: Actos | Byetta | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Insulin | Metformin | Middle East Health | Qatar Health | Study